Home/Filings/4/0001539215-25-000008
4//SEC Filing

Bhatt Padmanabh P. 4

Accession 0001539215-25-000008

CIK 0001356576other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:05 PM ET

Size

8.5 KB

Accession

0001539215-25-000008

Insider Transaction Report

Form 4
Period: 2025-12-18
Bhatt Padmanabh P.
Sr. VP of IP; CSO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-18+1,50015,218 total
  • Sale

    Common Stock

    2025-12-18$44.44/sh710$31,55214,508 total
  • Exercise/Conversion

    Performance Share Unit

    2025-12-181,5000 total
    Exercise: $0.00Common Stock (1,500 underlying)
Footnotes (2)
  • [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
  • [F2]On February 22, 2022, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022.

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1
  • filerCIK 0001539215

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:05 PM ET
Size
8.5 KB